Literature DB >> 496450

Relationship between erythrocyte sedimentation rate and serum C-reactive protein in rheumatoid arthritis.

L Walsh, P Davies, B McConkey.   

Abstract

Serum C-reactive protein (CRP) and the erythrocyte sedimentation rate (ESR) were compared in 241 patients with rheumatoid arthritis (RA). There was a positive linear correlation between the 2 measurements with a high degree of variability. Neither age nor duration of RA had a detectable influence. The relationship between CRP and ESR was, however, altered by treatment with gold, penicillamine, or high doses of prednisone. It is suggested that serum CRP is the more sensitive measurement, but that CRP and ESR do not have identical clinical significance.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 496450      PMCID: PMC1000372          DOI: 10.1136/ard.38.4.362

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  5 in total

1.  The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants.

Authors:  B McConkey; R A Crockson; A P Crockson
Journal:  Q J Med       Date:  1972-04

2.  The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis.

Authors:  B McConkey; R A Crockson; A P Crockson; A R Wilkinson
Journal:  Q J Med       Date:  1973-10

3.  Drug treatment of rheumatoid arthritis. A systematic approach.

Authors:  T J Constable; R A Crockson; A P Crockson; B McConkey
Journal:  Lancet       Date:  1975-05-24       Impact factor: 79.321

4.  Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment.

Authors:  R S Amos; R A Crockson; A P Crockson; L Walsh; B McConkey
Journal:  Br Med J       Date:  1978-05-27

5.  Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.

Authors:  R S Amos; T J Constable; R A Crockson; A P Crockson; B McConkey
Journal:  Br Med J       Date:  1977-01-22
  5 in total
  9 in total

1.  Association between chronic periodontitis and rheumatoid arthritis: a hospital-based case-control study.

Authors:  Rosamma Joseph; Sreeraj Rajappan; Sameera G Nath; Binoy J Paul
Journal:  Rheumatol Int       Date:  2012-01-07       Impact factor: 2.631

2.  Raised C-reactive protein response in rheumatoid arthritis patients with secondary Sjögren's syndrome.

Authors:  P Youinou; P Fauquert; Y L Pennec; B Bendaoud; P Katsikis; P Le Goff
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

3.  Plasma viscosity--a new appraisal of its use as an index of disease activity in rheumatoid arthritis.

Authors:  M E Pickup; J S Dixon; C Hallett; H A Bird; V Wright
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

4.  C-reactive protein levels in patients with rheumatoid arthritis: the impact of therapy.

Authors:  M Tishler; D Caspi; M Yaron
Journal:  Clin Rheumatol       Date:  1985-09       Impact factor: 2.980

5.  Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis.

Authors:  K M Sanders; A Hertzman; M R Escobar; B H Littman
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

6.  C-reactive protein in juvenile chronic arthritis: an indicator of disease activity and possibly amyloidosis.

Authors:  M Gwyther; H Schwarz; A Howard; B M Ansell
Journal:  Ann Rheum Dis       Date:  1982-06       Impact factor: 19.103

7.  Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis.

Authors:  T T Möttönen
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

8.  Urinary sialyloligosaccharide excretion as an indicator of disease activity in rheumatoid arthritis.

Authors:  C P Maury; O Wegelius
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

9.  Etanercept Inhibits B Cell Differentiation by Regulating TNFRII/TRAF2/NF-κB Signaling Pathway in Rheumatoid Arthritis.

Authors:  Xiao-Yu Cai; Yue Zhu; Chen Wang; Xiao-Yu Tang; Le Han; Jin-Ling Shu; Xian-Zheng Zhang; Fa-Qin Liang; Jing-Ru Ge; Li Xu; Dan Mei; Ling-Ling Zhang; Wei Wei
Journal:  Front Pharmacol       Date:  2020-05-12       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.